Rallybio Corporation (RLYB)
NASDAQ: RLYB · Real-Time Price · USD
9.41
+0.31 (3.47%)
Mar 20, 2026, 11:05 AM EDT - Market open

Rallybio Balance Sheet

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
FY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Cash & Equivalents
31.3713.924.4956.96175.33
Short-Term Investments
23.3651.6185.44112.04-
Cash & Short-Term Investments
54.7465.51109.93168.99175.33
Cash Growth
-16.45%-40.41%-34.95%-3.62%25.03%
Other Current Assets
6.522.334.8610.55.54
Total Current Assets
61.2567.84114.79179.5180.87
Net Property, Plant & Equipment
0.20.270.590.910.51
Long-Term Investments
--0.240.030.81
Other Long-Term Assets
0.81----
Total Assets
62.2668.11115.62180.44182.19
Accounts Payable
0.130.280.981.110.6
Accrued Expenses
3.794.968.079.455.95
Current Portion of Leases
0.090.150.220.18-
Unearned Revenue
0.210.85---
Total Current Liabilities
4.226.249.2610.746.55
Long-Term Leases
0.08-0.170.37-
Other Long-Term Liabilities
-0.21--0.03
Total Long-Term Liabilities
0.080.210.170.370.03
Total Liabilities
4.316.459.4411.126.58
Common Stock
00000
Additional Paid-in Capital
359.93354.6341.41330.21269.63
Accumulated Other Comprehensive Income
0.020.070.02-0.21-
Retained Earnings
-302-293.02-235.25-160.68-94.03
Shareholders' Equity
57.9661.65106.18169.32175.6
Total Liabilities & Equity
62.2668.11115.62180.44182.19
Total Debt
0.180.150.390.560
Net Cash (Debt)
54.5665.36109.54168.44175.33
Net Cash Growth
-16.52%-40.33%-34.97%-3.93%25.03%
Net Cash Per Share
9.6912.0121.6642.3554.97
Book Value
57.9661.65106.18169.32175.6
Book Value Per Share
10.3011.3321.0042.5755.05
Tangible Book Value
57.9661.65106.18169.32175.6
Tangible Book Value Per Share
10.3011.3321.0042.5755.05
Updated Dec 31, 2025. Data Source: Fiscal.ai. Standard template. Financial Sources.
SEC Filings: 10-K · 10-Q